The clinical utility of the cancer chemotherapeutic agent doxorubicin (DOX) is limited by its cardiotoxicity. Doxorubicinol (DOXol), the major biometabolite of DOX, preferentially accumulates in ...
US researchers have revealed the fingerprints of sudden infant death syndrome (SIDS) within blood samples, which could open the door to simple tests to identify babies at risk.